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Abstract—Remote ambulatory monitoring is widely seen as 
playing a key part in addressing the impending crisis in health 
care provision. We describe two mobile health solutions, one 
developed in the Netherlands and one in Australia. In both cases 
a patient’s biosignals are measured by means of body worn 
sensors which communicate wirelessly with a handheld device. 
Alarms and biosignals can be transmitted over wireless 
communication links to a remote location, and a remote health 
professional can view the biosignal data via a web application. 
The clinical purposes are similar, however the technological 
approaches differ in some respects. We compare the two 
approaches and the experience gained working with a number of 
different patient groups and clinical specialties during trials in 
Europe and Australia.  
Keywords- telemonitoring, teletreatment, mobile technology, 
mobile healthcare solutions, Personal health monitoring. 
1. Introduction 
M-health systems are attracting increasing interest since 
they offer personalised healthcare services to the patient whilst 
promising to alleviate pressure on the overburdened healthcare 
system by improving daily disease management, enabling 
automatic emergency and trend detection and facilitating self-
care. Many m-health systems are already in routine clinical use, 
typically incorporating a wearable or implanted device and 
running embedded software to perform a specific set of 
functions around one clinical application. We distinguish 
monitoring services from services which also provide some 
kind of treatment or intervention. Pacemakers, for example, 
combine monitoring with intervention. Such a system runs 
autonomously and transparently (the patient need not be aware 
of it or interact with it) in contrast with personal health systems 
where the patient actively interacts with the system; hence we 
distinguish also personal mobile services used by the patient to 
aid daily self-care. Local, personal services, which may be 
delivered by a standalone mobile system, are distinguished 
from teleservices, which involve long range communication 
with a remote healthcare location or health professional. 
Many systems available today are closed proprietary 
systems which provide a specific set of condition-specific 
services, eg. monitoring and disease management functions. In 
this paper we present a more generic, open approach which we 
believe will lead to more flexible and adaptable personal and 
telehealth services in future. We examine two different generic 
approaches developed by two groups of researchers: one in 
Australia and one in Europe.  
Members of the Telemedicine Group at the University of 
Twente in the Netherlands have been investigating the 
application of Body Area Network (BAN) technology in a 
number of clinical settings in order to offer remote monitoring 
and treatment services. The European system is known as 
MobiHealth. Several variants of the system were developed 
during a number of projects starting with IST MobiHealth [1-2] 
and currently continuing in MYOTEL [3]. Figure 1 shows the 
MYOTEL BAN. 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.  Myotel teletreatment BAN 
An alternative approach is applied at the University of 
Technology, Sydney, where a Personal Health Monitor (PHM), 
originally focusing on local, personal m-health services, has 
been developed and applied in various clinical settings [4-6].  
With both systems the patient wears body worn sensors and 
uses a handheld device which receives output from the sensor 
systems, runs a local application and acts as a communications 
gateway for (possible) onward transmission of data to a remote 
healthcare location. In the Australian system (Figure 2) the 
handheld device is a Microsoft Windows mobile phone. The 
European system has been implemented on a number of 
different PDAs and mobile phone platforms.  
 
 Figure 2.  Personal Health Monitor  
The two approaches share similar clinical goals, namely 
provision of routine chronic disease management functionality 
and/or detection of medical emergencies in different clinical 
settings. In both cases the philosophy is to design a generic 
mobile solution which can be adapted to different clinical 
applications, which is easy to wear and use and is as 
unobtrusive as possible. 
However the two teams utilise different approaches and 
different development technologies. Here we present the two 
approaches and compare the experience gained working with 
different patient groups and different clinical specialties in 
Europe and Australia. 
In Section 2 a generic architecture for m-health systems is 
presented. In Section 3 this architecture is used to compare the 
two systems. Section 4 describes the clinical applications 
developed so far by the two teams. Section 5 compares 
experience with users and Section 6 presents discussion and 
conclusions. 
2. A Generic Architecture for M-Health  
Here we describe a high level architecture (Figure 3) and 
terminology originally developed as part of the European 
research and apply it to compare the two systems and to test the 
genericity of the architecture.  
We view a BAN-based m-health system as a set of deployed 
BANs and a Back End. Communication between BANs and 
the Back End is via so-called extraBAN communication. To 
support pervasive services and full mobility for the user 
extraBAN communication should be wireless. IntraBAN 
communication may be wired, wireless or a mixture of the two. 
 
Figure 3.  Generic architecture for m-health 
A health BAN is defined as a network of communicating 
devices worn on, around or in the body which provides mobile 
health services to the user. A BAN consists of a Mobile Base 
Unit (MBU) and a set of BAN devices (e.g. sensors, actuators 
or other ‘wearable devices’). The MBU acts as a processing 
platform and communications gateway and is currently realised 
as a software application running on a handheld device. BAN 
data may be processed locally within the BAN and/or remotely, 
the latter implying transmission of data to a remote location. 
Front-end supported sensors are powered by a sensor front end 
which also digitizes and filters the raw analogue signal before 
transmitting the data over a wireless link to the MBU. 
In general, a health BAN may act as a standalone device 
providing personal local services to the patient. At the other 
end of the spectrum, all BAN data may be transmitted onward 
for processing, or a combination of local and remote processing 
may be used. If a remote user (human or software) is involved 
and extraBAN communication occurs then we can regard the 
m-health service as a telemedicine service. 
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In the Back End we distinguish functions which are 
concerned with management of BANs, their devices and BAN 
data from the clinical back end functions, which support 
application specific functionality and which may interface to 
healthcare providers’ information systems. 
 
 
 
 
3. Comparison of the implemented systems 
In this section we compare the two systems according to the 
architectural concepts outlined in the previous section. Table 1 
lists the respective features of the two systems by the major 
components identified in the architecture. 
 
 
TABLE I.  Features of the two systems by architectural components 
Component Personal Health Monitor MobiHealth  
BAN devices • Off-the-shelf sensor systems (front end 
supported). Sensors are non-invasive, 
good quality/price ratio, Bluetooth 
enabled. 
• Sensors: 1 channel ECG, weight scale, 
accelerometer, blood pressure monitor, 
blood glucose meter, pulse oximeter 
• Other: GPS.  
• Sensors, actuators, any other wearable device with 
(wireless or wired) communications interface.  
• Sensors: 3, 4 and 9 channel ECG, surface EMG,  
pulse oximeter, respiration sensor, temperature 
sensor, activity sensors (step-counter, 3D 
accelerometer). 
• Actuators: tactile feedback. 
• Other: GPS, alarm button. 
Sensor Front End • Subcomponent of commercial sensor 
system incorporating embedded 
software for signal processing. 
• Commercial sensor Front Ends (re)developed by 
industrial partners, with some programming of 
DSP to perform additional biosignal and other 
processing. 
MBU • Implemented on a mobile phone. 
• Any smart phone running Microsoft 
Windows Mobile OS. 
• Implemented on various mobile phones and 
PDAs. 
• Any mobile platform capable of running Java VM 
and RMI. 
Software on the MBU • Generic interface showing live data, 
reminders, battery status. 
• Admin. interface to configure 
reminders, sensors. 
• Algorithms to analyse ECG data and 
to advise user.  
• Application specific functionality and GUI 
running over generic BAN software layer and 
protocol stack. Example: seizure detection 
algorithm for epilepsy. 
Processing on the MBU • Philosophy: process locally all that can 
be automated and within processing 
capabilities of the mobile phone. This 
limits transfer of unnecessary data and 
provides immediate feedback to the 
patient. 
• Positioning (also indoors) using WiFi, 
GSM cell id and GPS. 
• Personalisation of sensor thresholds 
and emergency settings. 
• Customized audio warnings and 
informative messages. 
• Reminders per sensor. 
• Philosophy: design and optimize total chain of 
processing for each specific application; attempt 
to manage QoS in wireless and mobile 
environment by performing dynamic 
(re)allocation of processing tasks across the m-
health service platform including the MBU. 
• Positioning (outdoors) using GSM cell-id and 
GPS. 
• Context aware applications (adaptation to context 
including communications environment and 
patient’s environment). 
IntraBAN 
Communications 
• Wired, wireless (Bluetooth). 
 
• Wired, wireless (Bluetooth). 
ExtraBAN 
Communications 
• 3G, GSM, SMS, Internet. 
• Phone and SMS numbers can be 
personalised . 
• GPRS, UMTS, WiFi, Internet, SMS. 
• Vertical handover between transmission 
technologies (in response to changing cost, 
bandwidth availability, network congestion etc.). 
Back End • Any ISP offering Microsoft ASP.NET 
web hosting. 
• Generic interface for live data showing 
patients needing attention. 
• Generic interface for PHM 
administration. 
• Specific Interface for the specialist 
(cardiologist, personal assistant). 
• BAN Back End runs on PC or laptop set up as Jini 
server. Jini Surrogate Architecture used to 
represent and manage BANs, BAN devices and 
BAN data and give physicians access to BAN data 
and BAN management functions. Physician access 
via a generic m-health portal (web application) 
which is customized for each clinical application. 
Processing on Back End • Triage of life data which can be 
personalised to the application 
domain. 
• Generic BAN functionality. Application 
functionality specific to each individual clinical 
application and patient and HP user requirements. 
• Viewing and reporting for physician. 
• Physician can update sensor 
thresholds. 
• Remote management of PHM 
equipment and patients. 
• Password protected viewing by the 
patient (limited view). 
• Synchronisation between MBU and 
Back End. 
Generally, viewing, streaming and management 
services for BANs and BAN data, analysis and 
interpretation algorithms, alarms, geospatial and 
location-based services. 
• HPs can switch on BANs and BAN devices, alter 
sampling frequencies etc. 
• Mechanisms for feedback and treatment from 
HPs. 
• Various security and access control mechanisms.  
Trial Patient group(s) • 1 trial group: 70+ cardiac patients. 
• Trial in one centre in Sydney. 
• English speaking, Multi- ethnicity, 22-
90 years. 
• Low-medium risk patients. 
• 17 trial groups over 4 projects. 
• Multi centre international trials in Europe. 
• Multi-language. 
• Low risk patients. 
Clinical 
specialties/settings 
• Cardiology. 
• General well being. 
• Chronic disease management. 
• Rehabilitation. 
• Cardiology. 
• Obstetrics. 
• Trauma care. 
• Rheumatology. 
• Psychiatry. 
• Pulmonary medicine. 
• Gerontology. 
• Neurology. 
Clinical applications Monitoring  
• Cardiac Rhythm Monitoring. 
• Cardiac rehabilitation. 
• Primary prevention. 
Telemonitoring: 
• Ventricular arrhythmia. 
• High risk pregnancies. 
• Acute trauma  
• Rheumatoid arthritis. 
• Recently discharged patients in remote locations. 
• Mental health problems. 
• COPD rehabilitation. 
• Elderly patients with co-morbidities including 
COPD. 
• Epilepsy  
• Uncontrolled movements in spasticity. 
Telemonitoring/treatment: 
• chronic pain with whiplash or 
• with work-related neck and shoulder pain 
 
 
 
 
 
 
4. Clinical applications  
A. Personal Health Monitor 
Applications currently available include Cardiac Rhythm 
Monitoring (CRM), Cardiac Rehabilitation and primary 
prevention. The CRM application aims at detecting cardiac 
arrhythmia events which are not always detected by a Holter or 
Event monitor due to their sporadic nature. The study also 
investigates the usability and practicability of the system from 
both patients’ and physicians’ perspectives. A secondary aim is 
to investigate whether use of the PHM provides clinically 
meaningful reassurance to patients with suspected arrhythmias 
and other cardiac conditions. 
The Cardiac rehabilitation application aims at remote 
monitoring of a patient’s progress by a physician as well as 
motivating the patient to do his/her exercises. Studies show 
that, in order to improve long term clinical outcomes, patients 
need to make lifestyle changes following myocardial infarction 
or coronary bypass surgery. Many fail to do so. We investigate 
whether the PHM system can aid and motivate patients to 
achieve these life style changes by giving reminders and 
monitoring progress. 
B. MobiHealth BAN 
The mobile services provided can be characterized as 
telemonitoring or teletreatment services. Multi-centre 
international trials have been conducted in The Netherlands, 
Germany, Spain, Sweden and Cyprus. Different variants of the 
BAN have been trialled on a number of patient groups during 
the course of several research projects starting in 2002 with the 
MobiHealth project. Patients with ventricular arrhythmias were 
monitored by a health call centre. They wore BANs designed to 
detect dangerous arrhythmias as well as longer term trends in 
cardiac function. Pregnant women were monitored in order to 
detect premature labour and foetal distress. In the trauma trials 
ambulance paramedics used paramedic BANs to transfer image 
information from the scene to the hospital and applied trauma 
patient BANs to casualties to transmit vital signs to the 
hospital. Physical activity monitoring of women with 
rheumatoid arthritis was conducted in order to gather research 
data. Patients recently discharged from hospital to remote rural 
locations were remotely monitored by a physician or a 
registered district nurse, with the objective of preventing 
unnecessary (re)hospitalizations. Patients with mental health 
and other problems supported by a home alarm system were 
given a BAN equipped with positioning and an alarm button. 
The objective was to support these patients outside the home, 
thus freeing them up to full mobility. COPD patients used 
BANs for monitoring at home and during outdoor exercise 
during rehabilitation. Another trial used telemonitoring in 
homecare for elderly chronically ill patients.  
Cardiac, pregnancy and COPD monitoring were further 
trialled during the HealthService24 project. 
In Awareness epilepsy patients, chronic pain patients and 
patients with uncontrolled movements in spasticity were 
monitored.  
With Myotel we introduce teletreatment. Teletreatment 
involves local biofeedback and advice from a remote clinician. 
Telemonitoring and treatment services are trialled on chronic 
pain patients including patients with whiplash and patients with 
work-related neck/ shoulder pain.  
5. Experience with users 
A. Australian trials 
To date 70 low-medium risk cardiac patients, aged 22 to 90 
years old used the PHM system at a Sydney Hospital 
(Cardiology Department). The patients were given a heart 
monitor and a mobile phone to monitor and record their cardiac 
rhythm for a few weeks in their normal environment 
The trial already demonstrated that the detection of 
important cardiac arrhythmias is feasible using the PHM 
system compared to conventional Holter monitors. The ECG 
signal quality is in the majority of cases of sufficient quality for 
a cardiologist to make an assessment. 
Patients are able to record their cardiac rhythm when they 
feel something and the PHM records automatically if it detects 
an abnormal rhythm. “Catching” an arrhythmia event greatly 
improves satisfaction for those patients for whom nothing 
showed up on an ECG taken by the cardiologist. Most patients 
had no difficulty using a mobile phone and ECG sensor and the 
PHM application is straightforward to use. All patients who 
had used a Holter monitor found the PHM far less intrusive and 
more practical. Patients leading an active life appreciated the 
fact no one could see they were wearing sensors and being 
monitored . 
B. European trials 
Our experience working with healthcare organizations and 
clinicians has been almost exclusively positive over the course 
of the BAN research. However the clinicians who initiate or 
join such projects are often the enthusiastic early adopters of 
technology, so are not necessarily representative of all their 
professional colleagues. Technical failures (such as system 
instability and loss of network connectivity), sub-optimal 
interface design and a difficult (re)start sequence 
understandably cause irritation and confusion to users. 
Notwithstanding some such technical problems in the first 
generation prototypes the utility of the telemonitoring service 
was acknowledged by all classes of user: professionals and 
patients, who agreed that ‘a stable commercial product would 
be very useful’ and “the overall evaluation of the MobiHealth 
system showed that the need for, and advantages of, the system 
were clear to all users”. Preliminary results from Myotel 
indicate that continuous local biofeedback enables chronic pain 
patients to adapt their behaviour rapidly and results in long 
lasting treatment effects. Adding the telemedicine dimension 
with feedback from the remote therapist further improves 
clinical outcomes related to pain and disability. Patients reacted 
positively to a feature allowing them to view their biosignals in 
real time on the MBU and quickly learnt to ‘read’ the displays 
and use them to improve relaxation [3]. 
6. Discussion and conclusions 
The PHM system adopts the policy of local processing, 
with interpretation algorithms running locally on the mobile 
system worn by the patient. In contrast the MobiHealth BAN is 
designed to be inherently a telemedicine system so a core 
feature is transmission of data to a remote system or user. An 
added advantage of the distributed system is that more 
computationally expensive processing, which may exceed the 
capacity of the mobile device, can be applied at the server side. 
However delays and other complications may also arise 
through dependence on long range wireless links. 
The Australian team made a decision to focus on non-
invasive applications. For the European team, all applications 
so far have been non-invasive, but minimally invasive systems, 
including the use of implants, are not ruled out. The Australian 
PHM system originally aimed to provide personal mobile 
health services primarily for use by patients; later the back end 
web services for clinical users were added. In contrast, for the 
European team the teleservice aspect was central from the 
outset. The Australian PHM system targets personal 
monitoring specifically and associated disease and personal 
health management services, whilst the MobiHealth vision was 
always to provide m-health services for patients and health 
professionals by enabling virtual health care teams.  From the 
start the MobiHealth team aimed at teletreatment as well as 
telemonitoring. The European team also included the notion of 
BANS for health professionals as well as patients from the 
outset [2]. 
The European team began by defining a generic 
architecture for the MobiHealth BAN and its supporting 
system. The generic BAN is then specialised for each clinical 
application by integrating a specific set of devices and 
implementing the appropriate application functionality. In the 
current exercise, by applying the generic architecture we found 
that the concepts could be mapped onto the Australian PHM 
system and correspondences and differences could be identified 
by reference to that architecture.  
We express the generics using a layered architecture view, 
with the application specifics at the top layer. Where 
MobiHealth started with generics and moved to specialization, 
the PHM approach was to start with one clinical application 
and separate generic functionality from application details, then 
to transfer the generics from the first clinical application to 
other applications within cardiology. In contrast the 
MobiHealth BAN was applied in parallel to clinical settings 
from different specialties since the first prototype systems. The 
PHM system will be applied to other specialties than 
cardiology and already has other sensors integrated which can 
be reused in other applications (Weight scale, Blood Pressure 
monitor, Blood Glucose monitor and Pulse Oximeter). 
The emphasis on adaptability and genericity, and the level 
of ambition, together with the essential telemedicine 
dimension, come at the cost of a certain level of complexity, 
making the MobiHealth system relatively heavyweight 
compared to the PHM system, with its leaner, more light 
weight approach. 
Determinants for the success of telemedicine have been 
identified as (1) Technology, (2) Acceptance, (3) Financing, (4) 
Organization and (5) Policy and Legislation [7]. Since both the 
PHM and the MobiHealth BAN are targeting the same global 
market, we face the same challenges in terms of financing, 
policy and legislation. We therefore focus here on Technology 
and Acceptance. 
A. Technology 
The PHM uses off-the-shelf sensors. They are available on 
the market and their technology is mature. This means that to 
use the PHM for independent personal monitoring, a user only 
needs to have a Microsoft Windows Mobile phone, and to buy 
or rent the sensors. The user can then download the software 
onto the mobile phone and use it just like any other Windows 
Mobile application. Another advantage of using off the shelf 
sensors is that the health professionals trust those devices if 
they are FDA, TGA and/or CE, approved. Patients can claim 
sensor rental or purchase from Medicare or their private health 
insurance in some countries (e.g. in Australia, blood pressure 
and blood glucose monitors are reimbursed by health insurers).  
The PHM users had no real problem with the battery life of 
the mobile phone. Most people nowadays are used to 
recharging their phone regularly. The limited battery life of the 
mobile devices has been more problematic for the MobiHealth 
BAN due to the more experimental nature of the sensor front 
ends used. 
For the younger generation, using a mobile phone for local 
processing of sensor data is a natural choice. It might be 
expected that simpler devices would be more suitable for 
patients in their 70s or older. However, during the PHM trials, 
elderly patients were able to use the personal health monitoring 
application even if they never used a mobile phone before. 
Simplicity and motivation, not age, seem to be the key factors 
for technology acceptance. 
The European team always took the view that to support 
pervasive services and full mobility for the user extraBAN 
communication should be wireless. However, the PHM, with 
good reason, uses both wireless and wired communication 
extraBAN. The PHM has an option to use wired (USB) 
communication between phone and PC to allow 
synchronisation of non-urgent data with the web service over 
ADSL. It might seem awkward to European, Canadian and US 
readers who are used to excellent wireless coverage but this is a 
necessity in countries like Australia where wireless coverage is 
patchy and/or costly.  
Both PHM and MobiHealth BAN provide secure web 
access to display data and present information using different 
views. The PHM team chose also to give patients access to 
some data. This allows them for example to check on their 
progress or to show their data to their GP. In the MobiHealth 
system, the emphasis has been on clinician access to data but 
patient access to data can be given depending on the 
application requirements. An example is the Myotel 
myofeedback BAN [3], which allows patients to view their 
biosignals real time on the MBU. 
MobiHealth BANs do not operate in isolation but are 
supported by an m-health service platform. We make a clear 
separation between the BAN Back End System and the clinical 
back end. The professional users at the clinical back end 
manage BANs and access BAN data via the m-health portal. A 
corollary is that the MobiHealth BAN cannot operate in 
standalone mode. In contrast the Australian system can operate 
standalone as a personal mobile service and can provide useful 
services in the absence of cell phone coverage. The PHM 
system works even if none of the designated sensors are 
connected. 
The development environment used for the PHM is C# and 
.NET compact framework, so the PHM system is tied into 
Microsoft’s Windows Mobile operating system. However the 
system can be deployed onto any mobile phone running 
Windows Mobile and patients can be offered a range of 
phones. In the European solution, Java technology was selected 
for reasons of portability and platform independence, so in 
theory the system can be implemented on any mobile platform 
capable of running JVM and RMI. There may be some cost in 
terms of overhead associated with running non-native code. 
B. Acceptance 
Clinicians found the European system presents clinical 
information of diagnostic quality and both patients and 
clinicians saw the utility of the telemedicine services, providing 
the system was stable. Beyond this, evaluation results are 
specific to clinical settings and space does not permit review 
here. Detailed evaluation results are available for all trials at 
the project websites. 
The Australian trials showed that, for acceptance by 
patients and health professionals, it was important for the 
system to be useful, easy to use and personalised. Reliability 
and accuracy were essential for professional acceptance. CRM 
patients found that the PHM helped them to obtain a better 
diagnosis of their chronic condition. Some patients would have 
liked to have kept the PHM since it gave them peace of mind.  
The cardiologists confirmed that the data was of sufficient 
quality to identify the main arrhythmias and pauses. They 
found the PHM very useful for a category of patients who do 
not get symptoms during their visit to the specialist, and for 
people who faint for no apparent reason (syncope). Thanks to 
the recordings, they can for example find out the cause of the 
fainting and its duration. The cardiologist also makes a better 
impression on his patients suffering from chronic conditions. 
Instead of saying ‘sorry, I suspect you have this but I cannot 
confirm it without evidence’ he can refer to the PHM trials and 
say: ’use this and try and record the event’.  
The patients who used the PHM to monitor their wellbeing 
found it useful to be in charge of their health and keep track of 
their progress (e.g. they can work out what triggers changes in 
blood pressure). CRM patients found the PHM far less 
intrusive and more practical than the Holter monitor. During 
the trials the PHM back end was specialised to suit the 
requirements of a cardiologist (he can annotate ECGs, print 
reports etc.). This makes PHM a useful tool for cardiologists. 
Each user has different needs and preferences so it is 
important for the applications to be tailorable to patients’ and 
health professionals’ needs and requirements. The PHM trials 
highlighted that feedback not only depends on the clinical 
application but also on patient preferences. Some patients want 
to be in charge of their health, are aware of medical 
terminology and wish to get immediate feedback. Others prefer 
to use the application without any interaction because they do 
not wish to know what is happening as they find it stressful. 
Elderly patients living alone want audio reminders and 
warnings. Active people want the application to be as 
unobtrusive as possible. The flexibility of the PHM user 
interface allows personalisation of feedback to the user. 
Overall, we can say that the MobiHealth system, which has 
been in development for longer than the PHM, is a complex but 
generic distributed system mediating between patients and 
healthcare organisations and designed for provision of a wide 
range of telemedicine services. The PHM system was 
originally focussed on a specific application relating to patient 
self-care, but is extending by evolutionary development both 
vertically (additional applications) and horizontally (by 
developing the clinical back end).  
In the introduction we identified some dimensions whereby 
m-health services may be classified. MobiHealth focussed on 
physician care and remote processing whereas PHM focussed 
on patient self-care and local processing. PHM deals with 
monitoring, the latest MobiHealth BAN in Myotel with 
monitoring and treatment. PHM tended initially toward patient 
interaction and MH to transparent services at the patient’s end. 
PHM began with acute applications whilst MH targeted both 
acute and chronic care. 
This article shows that the two teams are applying different 
design and technology choices, and addressing different focal 
points (telemedicine versus personal health management). 
Despite the differences in technologies and approach to generic 
m-health service provision, the two systems however are 
converging in relation to most of the identified dimensions. 
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